VDA-1214

N/A

Report date: 2022/08/23 20:00:44
NME

Base Information

Drug NameVDA-1214
Drug Alias NameVDA1214
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKeratinocytes modulatorsVoltage-dependent anion channels modulatorsVoltage-gated sodium channels modulators +[4] 
TargetsVoltage-dependent anion channelsVoltage-gated sodium channelsVoltage-gated potassium channel
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVidac Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVidac Pharma
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A